Head-to-head intra-individual comparison of [Ga-68]-FAPI and [F-18]-FDG PET/CT in patients with bladder cancer

Novruzov, E.Dendl, K.Ndlovu, HonestChoyke, P.L.Dabir, M.Beu, M.Novruzov, F.Mehdi, E.Guliyev, F.Koerber, S.A.Lawal, I.Niegisch, G.Debus, J.Haberkorn, U.Sathekge, Mike MachabaGiesel, F.L.2023-07-182023-07-182022-08Novruzov, E., Dendl, K., Ndlovu, H. et al. Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer. Molecular Imaging and Biology 24, 651–658 (2022). https://doi.org/10.1007/s11307-022-01715-3.1536-1632 (print)1860-2002 (online)10.1007/s11307-022-01715-3http://hdl.handle.net/2263/91515DATA AVAILABILITY : The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.Please read abstract in the article.en© The Author(s), 2022. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.Fibroblast activation protein (FAP)Positron emission tomography (PET)Bladder cancerUrothelial carcinomaFibroblast activation protein inhibitor (FAPI)SDG-03: Good health and well-beingHead-to-head intra-individual comparison of [Ga-68]-FAPI and [F-18]-FDG PET/CT in patients with bladder cancerArticle